153 related articles for article (PubMed ID: 17524807)
1. Biomarkers of treatment response in clinical trials of novel antituberculosis agents.
Perrin FM; Lipman MC; McHugh TD; Gillespie SH
Lancet Infect Dis; 2007 Jul; 7(7):481-90. PubMed ID: 17524807
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for TB treatment response: challenges and future strategies.
Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activity.
Davies GR
Tuberculosis (Edinb); 2010 May; 90(3):171-6. PubMed ID: 20382567
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis biomarkers discovery: developments, needs, and challenges.
Wallis RS; Kim P; Cole S; Hanna D; Andrade BB; Maeurer M; Schito M; Zumla A
Lancet Infect Dis; 2013 Apr; 13(4):362-72. PubMed ID: 23531389
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and surrogate end points in clinical trials of tuberculosis treatment.
Davies GR; Phillips PP; Nunn AJ
J Infect Dis; 2007 Aug; 196(4):648-9; author reply 649-50. PubMed ID: 17624855
[No Abstract] [Full Text] [Related]
8. Enabling biomarkers for tuberculosis control.
Maertzdorf J; Weiner J; Kaufmann SH
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1140-8. PubMed ID: 22871324
[TBL] [Abstract][Full Text] [Related]
9. Sustainable tuberculosis drug development.
Wallis RS
Clin Infect Dis; 2013 Jan; 56(1):106-13. PubMed ID: 23042970
[TBL] [Abstract][Full Text] [Related]
10. Antituberculosis drug research: a critical overview.
Beena ; Rawat DS
Med Res Rev; 2013 Jul; 33(4):693-764. PubMed ID: 22622957
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for tuberculosis disease activity, cure, and relapse.
Wallis RS; Doherty TM; Onyebujoh P; Vahedi M; Laang H; Olesen O; Parida S; Zumla A
Lancet Infect Dis; 2009 Mar; 9(3):162-72. PubMed ID: 19246020
[TBL] [Abstract][Full Text] [Related]
12. The quest for biomarkers in tuberculosis.
Parida SK; Kaufmann SH
Drug Discov Today; 2010 Feb; 15(3-4):148-57. PubMed ID: 19854295
[TBL] [Abstract][Full Text] [Related]
13. Using animal models to develop new treatments for tuberculosis.
Nuermberger E
Semin Respir Crit Care Med; 2008 Oct; 29(5):542-51. PubMed ID: 18810687
[TBL] [Abstract][Full Text] [Related]
14. Rapid determination of growth inhibition of Mycobacterium tuberculosis by GC-MS/MS quantitation of tuberculostearic acid.
Cai G; Pauli GF; Wang Y; Jaki BU; Franzblau SG
Tuberculosis (Edinb); 2013 May; 93(3):322-9. PubMed ID: 23454100
[TBL] [Abstract][Full Text] [Related]
15. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development.
Nguyen L; Pieters J
Annu Rev Pharmacol Toxicol; 2009; 49():427-53. PubMed ID: 19281311
[TBL] [Abstract][Full Text] [Related]
17. Antituberculosis drugs: ten years of research.
Janin YL
Bioorg Med Chem; 2007 Apr; 15(7):2479-513. PubMed ID: 17291770
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
Pulido F; Iribarren JA; Kindelan JM; Moreno S
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
[TBL] [Abstract][Full Text] [Related]
19. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
20. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.
Mitchison DA
Soc Appl Bacteriol Symp Ser; 1996; 25():72S-80S. PubMed ID: 8972122
[No Abstract] [Full Text] [Related]
[Next] [New Search]
